Skip to main content
Premium Trial:

Request an Annual Quote

NuGen, Genome Institute of Singapore Collaborate on Amplification System

NEW YORK, Oct. 15-California's NuGen Technologies will work with researchers at the Genome Institute of Singapore to develop microarray-based amplification and gene expression analysis technologies, the company said today.

 

The partners will develop NuGen's Single Primer Isothermal Amplification platform, which is a linear amplification technique. Researchers will adapt its gene expression application, Ribo-SPIA, to work with the Singaporean institute's custom-made oligonucleotide microarrays.

 

Financial details of the partnership were not revealed.

 

NuGen is a privately held company based in San Carlos, Calif. The company is working to develop a gene expression analysis product that can function with sample sizes of less than 20 ng of RNA.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.